International alliances
AiCuris
AiCuris Anti-infective Cures AG (AiCuris) is a leading pharmaceutical company focussing on novel drug candidates for the prevention and treatment of severe and potentially life-threatening infectious diseases in immunocompromised patients and product candidates in clinical development.
As part of a cooperation and licence option agreement signed in 2023, AiCuris and the DZIF are working together to identify novel targets for antiviral therapies and to research new active substances for the treatment and prophylaxis of infections in immunocompromised patients. AiCuris has the option of licensing the active substances resulting from the collaboration for further development and worldwide commercialisation.